Calidi Biotherapeutics

company

About

Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.

  • 11 - 50

Details

Last Funding Type
Convertable Note
Last Funding Money Raised
$8.17M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the utilization of oncolytic viruses through an allogeneic cell-based delivery system.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8.17M
Calidi Biotherapeutics has raised a total of $8.17M in funding over 2 rounds. Their latest funding was raised on Jan 21, 2020 from a Convertable Note round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 21, 2020 Convertable Note $8.17M 2 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Calidi Biotherapeutics has made 1 investments. Their most recent investment was on Nov 16, 2022, when Virtualness raised $8M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 16, 2022 Virtualness
Seed $8M Information Technology

Investors

Number of Lead Investors
Number of Investors
2
Calidi Biotherapeutics is funded by 2 investors. Greentable Co., Ltd. and Won & Partners are the most recent investors.
Investor Name Lead Investor Funding Round
Greentable Co., Ltd. Convertable Note
Won & Partners Convertable Note